Does Analysis of the Antigenic Specificities of Anti-Neutrophil Cytoplasmic Antibodies Contribute to Their Clinical Significance in the Inflammatory Bowel Diseases?

References

• Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiolical potential. Kidney Int 1994;46:1–15.
   Google Scholar
• Saxon A, Shanahan F, Landers CJ, Ganz T, Targan SR. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86:202–10.
   Google Scholar
• Rump JA, Schölmerich J, Gross V, Roth M, Helfesrieder R, Rautmann A, et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn’s disease. Immunobiology 1990;181:406–13.
   PubMed Web of Science ®Google Scholar
• Mulder AHL, Broekroelofs J, Horst G, Limburg PC, Nelis GF, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates. Clin Exp Immunol 1994;95:490–7.
   PubMed Web of Science ®Google Scholar
• Peen E, Almer S, Bodemar G, Ryden BO, Sjölin C, Tejle K, et al. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn’s disease. Gut 1993;34:56–62.
   Google Scholar
• Stoffel MP, Csernok E, Herzberg C, Johnston T, Carroll SF, Gross WL. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Clin Exp Immunol 1996;104:54–9.
   PubMed Web of Science ®Google Scholar
• Walmsley RS, Zhao MH, Hamilton ML, Brownlee A, Chapman P, Pounder RE, et al. Anti-neutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease. Gut 1997;40:105–9.
   PubMed Web of Science ®Google Scholar
• Mayet WJ, Hermann E, Finsterwalder J, Rieder H, Poralla T, Meyer zum Buschenfelde KH. Antibodies to cathepsin G in Crohn’s disease. Eur J Clin Invest 1992;22:427–33.
   PubMedGoogle Scholar
• Lesavre P, Noel LH, Gayno S, Nusbaum P, Reumaux D, Erlinger S, et al. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (p-ANCA): specificity and clinical associations. J Autoimmun 1993;6:185–95.
   PubMedGoogle Scholar
• Schmitt WH, Csernok E, Flesch BK, Hauschild S, Gross WL. Autoantibodies directed against lysozyme: a new target antigenfor anti-neutrophil cytoplasmic antibodies (ANCA). Adv Exp Med Biol 1993;336:267–72.
   Google Scholar
• Kossa K, Coulthart A, Ives CT, Pusey CD, Hodgson HJF. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995;7:783–9.
   Google Scholar
• Sobajima J, Ozaki S, Osakada F, Uesugi H, Shirakawa H, Yoshida M, et al. Novel autoantigens of perinuclear antineutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2. Clin Exp Immunol 1997;107:135–40.
   PubMed Web of Science ®Google Scholar
• Cohavy O, Eggena MP, Parseghian M, Hamkalo B, Targan SR, Gordon LK, et al. Histone H1, a candidate pANCA antigen in ulcerative colitis [abstract]. Gastroenterology 1997;112:A951.
   Google Scholar
• Roozendaal C, Zhao MH, Horst G, Lockwood CM, Kleibeuker JH, Limburg PC, et al. Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel diseases. Clin Exp Immunol 1998;112:10–6.
   PubMedGoogle Scholar
• Sobajima J, Ozaki S, Okazaki T, Osakada F, Sumita S, Mori K, et al. Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type. Clin Exp Immunol 1996; 105. p. 120–4.
   Google Scholar
• Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc 1996;71:431–6.
   PubMed Web of Science ®Google Scholar
• Vasiliauskas EA, Plevy SE, Landers CJ, Binder SW, Ferguson DM, Yang H, et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn’s disease define a clinical subgroup. Gastroenterology 1996;110:1810–9.
   PubMed Web of Science ®Google Scholar
• Lo SK, Fleming KA, Chapman RWG. Prevalence of antineutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut 1992;33:1370–5.
   Google Scholar
• Schumacher G, Kollberg B, Sandstedt B, Ljungh A, Nässberger L. Circulating granulocyte antibodies in first attacks of colitis. Scand J Gastroenterol 1995;30:157–63.
   PubMed Web of Science ®Google Scholar
• O’Morain C, Tobin A, Leen E, Suzuki Y, O’Riordan T. Criteria of case definition in Crohn’s disease and ulcerative colitis. Scand J Gastroenterol 1989;24 Suppl 170:7–11.
   Google Scholar
• Van Hees PAM, Van Elteren PH, Van Lier HJJ, Van Tongeren JHM. An index of inflammatory activity in patients with Crohn’s disease. Gut 1980;21:279–86.
   PubMed Web of Science ®Google Scholar
• Kieldsen J, Schaffalitzky de Muckadell OB. Assessment of disease severity and activity in inflammatory bowel disease. Scand J Gastroenterol 1993;28:1–9.
   PubMedGoogle Scholar
• Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, Van Es LA, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1985;1:425–9.
   PubMed Web of Science ®Google Scholar
• Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989;97 Suppl 6:12–3.
   Google Scholar
• Van der Giessen M, Huitema MG, Cohen Tervaert JW, Kallenberg CGM. A technical note on the routinely performed ANCA detection. APMIS 1989;97 Suppl 6:37.
   Google Scholar
• Goldschmeding R, Van der Schoot CE, Ten Bokkel Huinink D, Hack CE, Van den Ende ME, Kallenberg CGM, et al. Wegener’s granulomatosis autoantibodies identify a novel diisopropyl fluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989;84:1577–87.
   PubMed Web of Science ®Google Scholar
• Zhao MH, Jones SJ, Lockwood CM. Bactericidal/ permeability increasing protein (BPI) is an important antigen for antineutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 1995;99:49–56.
   Google Scholar
• Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallenberg CGM. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993;17:411–7.
   PubMed Web of Science ®Google Scholar
• Reumaux D, Colombel JF, Duclos B, Chaussade S, Belaïche J, Jacquot S, et al. Antineutrophil cytoplasmic auto-antibodies in sera from patients with ucerative colitis after proctocolectomy with ileo-anal anastomosis. Adv Exp Med Biol 1993;336:523–5.
   Google Scholar
• Patel RT, Stokes R, Birch D, Ibbotson J, Keighley MRB. Influence of total colectomy on serum antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Br J Surg 1994;81:724–6.
   Google Scholar
• Freeman HJ, Roeck B, Devine DV, Carter CJ. Atypical perinuclear antineutrophil cytoplasmic antibodies after colectomy in inflammatory bowel disease. Can J Gastroenterol 1997;11:305–10.
   PubMedGoogle Scholar
• Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 1992;33:657–62.
   Google Scholar
• Broekroelofs J, Mulder AHL, Nelis GF, Westerveld BD, Cohen Tervaert JW, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD): relation to disease pattern and disease activity. Dig Dis Sci 1994;39:545–9.
   PubMed Web of Science ®Google Scholar
• Deusch K, Oberstadt K, Schaedel W, Weber M, Classen M. PANCA as a diagnostic marker in ulcerative colitis. Adv Exp Med Biol 1993;336:527–31.
   PubMedGoogle Scholar
• Orth T, Kellner R, Diekmann O, Faust J, Meyer zum Buschenfelde KH, Mayet WJ. Identification and characterization of autoantibodies against catalase and α-enolase in patients with primary sclerosing cholangitis. Clin Exp Immunol 1998;112:507–15.
   Google Scholar
• Moodie FDL, Leaker B, Cambridge G, Totty NF, Segal AW. Alpha-enolase: a novel cytosolic autoantigen in ANCA positive vasculitis. Kidney Int 1993;43:675–81.
   Google Scholar
• Akisawa N, Maeda T, Iwasaki S, Onishi S. Identification of an autoantibody against alpha-enolase in primary biliary cirrhosis. J Hepatol 1997;26:845–51.
   PubMedGoogle Scholar
• Brownlee A, Major JR, Lockwood CM. Heat treatment of sera unmasks antibodies to bactericidal/permeability-increasing protein (BPI) [abstract]. Sarcoidosis 1996;13:266.
   Google Scholar
• Kallenberg CGM, Cohen Tervaert JW, Limburg PC. ELISA for the detection of antibodies against neutrophil cytoplasm antigens. Tech Diagn Pathol 1991;2:43–60.
   Google Scholar
• Coremans IEM, Hagen EC, Daha MR, Van der Woude FJ, Van der Voort EAM, Kleyburg-Van der Keur C, et al. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 1992;35:1466–75.
   PubMedGoogle Scholar
• Jones SJ, Zhao MH, Elliott JD, Lockwood CM. The antigenicity of bactericidal/permeability-increasing protein (BPI) is threatened by serine proteases [abstract]. Clin Exp Immunol 1995; 101 Suppl 1:36.
   Google Scholar
• Franssen CFM, Gans RO, Arends B, Hageluken C, Ter Wee PM, Gerlag PG, et al. Differences between anti-myeloperoxidase and anti-proteinase 3-associated renal disease. Kidney Int 1995; 47. p. 193–9.
   PubMedGoogle Scholar
• Falk RJ, Terrel RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115–9.
   PubMed Web of Science ®Google Scholar
• Heeringa P, Brouwer E, Cohen Tervaert JW, Weening JJ, Kallenberg CGM. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidney Int 1998;53:253–63.
   Google Scholar
• Roozendaal C, Kallenberg CGM. Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease? Clin Exp Immunol 1999;116:206–13.
   PubMed Web of Science ®Google Scholar
• Cohavy O, Targan SR, Gordon LK, Braun J. Molecular mimicry? Molecular characterization of E. coli and Bacteroides proteins that are reactive with pANCA monoclonal antibodies [abstract]. Gastroenterology 1999;116:G2975.
   Google Scholar